ArticleMedicine2017

Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST): A case report.

Xingchen Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.